Antonelli A. Ferrari S.M. Giuggioli D. et al.

Hepatitis C virus infection and type 1 and type 2 diabetes mellitus [J].

World J Diabetes. 5: 586-600

Environmental and genetic contributions to diabetes [J].

Metabolism. 100S: 153952International Diabetes Federation

[J]. IDF diabetes Atlas.

8th ed. International Diabetes Federation, Brussels, Belgium

Correction to: epidemiology of diabetes and diabetic complications in China [J].

Diabetologia. 61: 1491Hill M.A. Yang Y. Zhang L. et al.

Insulin resistance, cardiovascular stiffening and cardiovascular disease [J].

Metabolism. 119: 154766WHO, global hepatitis report

New hepatitis data highlight need for urgent global response.

World Health Organization, Takamizawa A. Mori C. Fuke I. et al.

Structure and organization of the hepatitis C virus genome isolated from human carriers [J].

J Virol. 65: 1105-1113

Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties [J].

Curr Top Microbiol Immunol. 242: 55-84Hong Y.S. Chang Y. Ryu S. et al.

Hepatitis B and C virus infection and diabetes mellitus: a cohort study [J].

Sci Rep. 7: 4606Chehadeh W. Kurien S.S. Abdella N. et al.

Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications [J].

J Infect Public Health. 4: 200-206Zampino R. Coppola N. Cirillo G. et al.

Insulin resistance and steatosis in HBV-HCV co-infected patients: role of PNPLA3 polymorphisms and impact on liver fibrosis progression [J].

World J Hepatol. 6: 677-684De Luca A. Lorenzini P. Castagna A. et al.

Active HCV replication but not HCV or CMV seropositive status is associated with incident and prevalent type 2 diabetes in persons living with HIV [J].

J Acquir Immune Defic Syndr. 75: 465-471Wang C.S. Wang S.T. Yao W.J. et al.

Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study [J].

Am J Epidemiol. 166: 196-203White D.L. Ratziu V. El-Serag H.B.

Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis [J].

J Hepatol. 49: 831-844Gastaldi G. Goossens N. Clement S. et al.

Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: a review [J].

J Adv Res. 8: 149-159Chen J. Wang F. Zhou Y. et al.

Chronic hepatitis C virus infection impairs insulin secretion by regulation of p38delta MAPK-dependent exocytosis in pancreatic beta-cells [J].

Clin Sci (Lond). 134: 529-542Willeit P. Skroblin P. Moschen A.R. et al.

Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes [J].

Diabetes. 66: 347-357Singhal A. Agrawal A. Ling J.

Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: a driver function of circulating miRNAs [J].

J Cell Mol Med. 22: 2071-2085Lonardo A. Adinolfi L.E. Petta S. et al.

Hepatitis C and diabetes: the inevitable coincidence? [J].

Expert Rev Anti Infect Ther. 7: 293-308Naing C. Mak J.W. Ahmed S.I. et al.

Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis [J].

World J Gastroenterol. 18: 1642-1651Mehta S.H. Brancati F.L. Sulkowski M.S. et al.

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States [J].

Ann Intern Med. 133: 592-599Mangia A. Schiavone G. Lezzi G. et al.

HCV and diabetes mellitus: evidence for a negative association [J].

Am J Gastroenterol. 93: 2363-2367Ruhl C.E. Menke A. Cowie C.C. et al.

Relationship of hepatitis C virus infection with diabetes in the U.S. population [J].

Hepatology. 60: 1139-1149Aghemo A. Prati G.M. Rumi M.G. et al.

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C [J].

Hepatology. 56: 1681-1687Pavone P. Tieghi T. D’ettorre G. et al.

Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents [J].

Clin Microbiol Infect. 22 (): 462Butt A.A. Yan P. Aslam S. et al.

Hepatitis C virus (HCV) treatment with directly acting agents reduces the risk of incident diabetes: results from electronically retrieved cohort of HCV infected veterans (ERCHIVES) [J].

Clin Infect Dis. 70: 1153-1160

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM [J].

Diabetes. 37: 667-687Leclercq I.A. Da Silva Morais A. Schroyen B. et al.

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences [J].

J Hepatol. 47: 142-156

The IRS-signalling system: a network of docking proteins that mediate insulin action [J].

Mol Cell Biochem. 182: 3-11Kido Y. Nakae J. Accili D.

Clinical review 125: the insulin receptor and its cellular targets [J].

J Clin Endocrinol Metab. 86: 972-979Vanhaesebroeck B. Alessi D.R.

The PI3K-PDK1 connection: more than just a road to PKB [J].

Biochem J. 346: 561-576

AKT signaling in normal and malignant cells [J].

Oncogene. 24: 7391-7393

Insulin signalling and the regulation of glucose and lipid metabolism [J].

Nature. 414: 799-806Gao J. He X. Ma Y. et al.

Chlorogenic acid targeting of the AKT PH domain activates AKT/GSK3beta/FOXO1 signaling and improves glucose metabolism [J].

Nutrients. 10

Liver and insulin resistance: new wine in old bottle!!! [J].

Eur J Pharmacol. 862: 172657Yasui K. Wakita T. Tsukiyama-Kohara K. et al.

The native form and maturation process of hepatitis C virus core protein [J].

J Virol. 72: 6048-6055

Hepatitis C virus core protein: intriguing properties and functional relevance [J].

FEMS Microbiol Lett. 202: 149-156Tamemoto H. Kadowaki T. Tobe K. et al.

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 [J].

Nature. 372: 182-186Withers D.J. Gutierrez J.S. Towery H. et al.

Disruption of IRS-2 causes type 2 diabetes in mice [J].

Nature. 391: 900-904

Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 [J].

Diabetologia. 55: 2565-2582Banerjee S. Saito K. Ait-Goughoulte M. et al.

Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance [J].

J Virol. 82: 2606-2612Aytug S. Reich D. Sapiro L.E. et al.

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes [J].

Hepatology. 38: 1384-1392Cua I.H. Hui J.M. Bandara P. et al.

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines [J].

Hepatology. 46: 66-73Knobler H. Zhornicky T. Sandler A. et al.

Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association [J].

Am J Gastroenterol. 98: 2751-2756Greenberg A.S. Mcdaniel M.L.

Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes [J].

Eur J Clin Invest. 32: 24-34Moriishi K. Okabayashi T. Nakai K. et al.

Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein [J].

J Virol. 77: 10237-10249Miyamoto H. Moriishi K. Moriya K. et al.

Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein [J].

J Virol. 81: 1727-1735Peyrou M. Bourgoin L. Foti M.

PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer [J].

Dig Dis. 28: 236-246Gao T.T. Qin Z.L. Ren H. et al.

Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner [J].

Virol J. 12: 12Solinas G. Naugler W. Galimi F. et al.

Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates [J].

Proc Natl Acad Sci U S A. 103: 16454-16459Garcia-Monzon C. Lo Iacono O. Mayoral R. et al.

Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C [J].

J Hepatol. 54: 142-152Deng L. Chen M. Tanaka M. et al.

HCV upregulates Bim through the ROS/JNK signalling pathway, leading to Bax-mediated apoptosis [J].

J Gen Virol. 96: 2670-2683Valgimigli M. Valgimigli L. Trere D. et al.

Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation [J].

Free Radic Res. 36: 939-948Ivanov A.V. Smirnova O.A. Ivanova O.N. et al.

Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells [J].

PLoS One. 6e24957Houstis N. Rosen E.D. Lander E.S.

Reactive oxygen species have a causal role in multiple forms of insulin resistance [J].

Nature. 440: 944-948Ivanov A.V. Smirnova O.A. Petrushanko I.Y. et al.

HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells [J].

Viruses. 7: 2745-2770Kamata H. Honda S. Maeda S. et al.

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases [J].

Cell. 120: 649-661Lochhead P.A. Coghlan M. Rice S.Q. et al.

Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression [J].

Diabetes. 50: 937-946Parvaiz F. Manzoor S. Iqbal J. et al.

Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis [J].

World J Gastroenterol. 21: 12361-12369Parvaiz F. Manzoor S. Iqbal J. et al.

Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome [J].

Arch Virol. 159: 1017-1025Carlson C.J. Koterski S. Sciotti R.J. et al.

Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression [J].

Diabetes. 52: 634-641Tsutsumi T. Suzuki T. Moriya K. et al.

Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice [J].

Hepatology. 38: 820-828Chen W.C. Tseng C.K. Chen Y.H. et al.

HCV NS5A up-regulates COX-2 expression via IL-8-mediated activation of the ERK/JNK MAPK pathway [J].

PLoS One. 10e0133264Zhao L.J. Wang L. Ren H. et al.

Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors [J].

Exp Cell Res. 305: 23-32Gual P. Le Marchand-Brustel Y. Tanti J.F.

Positive and negative regulation of insulin signaling through IRS-1 phosphorylation [J].

Biochimie. 87: 99-109Alberstein M. Zornitzki T. Zick Y. et al.

Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression [J].

J Viral Hepat. 19: 65-71Pazienza V. Clement S. Pugnale P. et al.

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms [J].

Hepatology. 45: 1164-1171Zhang J.G. Farley A. Nicholson S.E. et al.

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation [J].

Proc Natl Acad Sci U S A. 96: 2071-2076Kawaguchi T. Yoshida T. Harada M. et al.

Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 [J].

Am J Pathol. 165: 1499-1508Pazienza V. Vinciguerra M. Andriulli A. et al.

Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR- in Huh-7 cells [J].

J Gen Virol. 91: 1678-1686Haruta T. Uno T. Kawahara J. et al.

A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1 [J].

Mol Endocrinol. 14: 783-794

Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis [J].

Cancer Biol Ther. 2: 471-476Tremblay F. Brule S. Hee Um S. et al.

Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance [J].

Proc Natl Acad Sci U S A. 104: 14056-14061Bose S.K. Shrivastava S. Meyer K. et al.

Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance [J].

J Virol. 86: 6315-6322Hajduch E. Litherland G.J. Hundal H.S.

Protein kinase B (PKB/Akt)--a key regulator of glucose transport? [J].

FEBS Lett. 492: 199-203Kamibayashi C. Estes R. Lickteig R.L. et al.

Comparison of heterotrimeric protein phosphatase 2A containing different B subunits [J].

J Biol Chem. 269: 20139-20148Zhou J. Pham H.T. Walter G.

The formation and activity of PP2A holoenzymes do not depend on the isoform of the catalytic subunit [J].

J Biol Chem. 278: 8617-8622Liberman E. Fong Y.L. Selby M.J. et al.

Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein [J].

J Virol. 73: 3718-3722

Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response [J].

FASEB J. 19: 1510-1512Benali-Furet N.L. Chami M. Houel L. et al.

Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion [J].

Oncogene. 24: 4921-4933Christen V. Treves S. Duong F.H. et al.

Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A [J].

Hepatology. 46: 558-565Tardif K.D. Waris G. Siddiqui A.

Hepatitis C virus, ER stress, and oxidative stress [J].

Trends Microbiol. 13: 159-163Bernsmeier C. Duong F.H. Christen V. et al.

Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C [J].

J Hepatol. 49: 429-440Banerjee A. Meyer K. Mazumdar B. et al.

Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression [J].

J Virol. 84: 5936-5946Lerat H. Imache M.R. Polyte J. et al.

Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice [J].

J Biol Chem. 292: 12860-12873Rubbia-Brandt L. Quadri R. Abid K. et al.

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 [J].

J Hepatol. 33: 106-115

Is genotype 3 of the hepatitis C virus the new villain? [J].

Hepatology. 59: 2403-2412Lonardo A. Adinolfi L.E. Restivo L. et al.

Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen [J].

World J Gastroenterol. 20: 7089-7103Leandro G. Mangia A. Hui J. et al.

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data [J].

Gastroenterology. 130: 1636-1642Lonardo A. Ballestri S. Guaraldi G. et al.

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - evidence from three different disease models: NAFLD, HCV and HIV [J].

World J Gastroenterol. 22: 9674-9693

Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases [J].

J Hepatol. 61: S69-S78Birkenfeld A.L. Shulman G.I.

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes [J].

Hepatology. 59: 713-723Ilonen J. Lempainen J. Veijola R.

The heterogeneous pathogenesis of type 1 diabetes mellitus [J].

Nat Rev Endocrinol. 15: 635-650Laskus T. Radkowski M. Wang L.F. et al.

Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues [J].

Hepatology. 28: 1398-1401Masini M. Campani D. Boggi U. et al.

Hepatitis C virus infection and human pancreatic beta-cell dysfunction [J].

Diabetes Care. 28: 940-941Blackard J.T. Kong L. Lombardi A. et al.

A preliminary analysis of hepatitis C virus in pancreatic islet cells [J].

Virol J. 14: 237Wang Q. Chen J. Wang Y. et al.

Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway [J].

PLoS One. 7e38522Hou J.C. Min L. Pessin J.E.

Insulin granule biogenesis, trafficking and exocytosis [J].

Vitam Horm. 80: 473-506Sumara G. Formentini I. Collins S. et al.

Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis [J].

Cell. 136: 235-248Lecube A. Hernandez C. Genesca J. et al.

Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study [J].

Diabetes Care. 29: 1096-1101Milner K.L. Van Der Poorten D. Trenell M. et al.

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance [J].

Gastroenterology. 138 (): 932-941Frigerio S. Junt T. Lu B. et al.

Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis [J].

Nat Med. 8: 1414-1420Miao M. De Clercq E. Li G.

Clinical significance of chemokine receptor antagonists [J].

Expert Opin Drug Metab Toxicol. 16: 11-30Lacotte S. Brun S. Muller S. et al.

CXCR3, inflammation, and autoimmune diseases [J].

Ann N Y Acad Sci. 117: 310-317Antonelli A. Ferrari S.M. Corrado A. et al.

CXCR3, CXCL10 and type 1 diabetes [J].

Cytokine Growth Factor Rev. 25: 57-65Gabbay M.A. Sato M.N. Duarte A.J. et al.

Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [J].

Clin Exp Immunol. 168: 60-67Morimoto J. Yoneyama H. Shimada A. et al.

CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis [J].

J Immunol. 173: 7017-7024Uno S. Imagawa A. Saisho K. et al.

Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes [J].

Endocr J. 57: 991-996Itoh Y. Morita A. Nishioji K. et al.

Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels [J].

J Viral Hepat. 8: 341-348Apolinario A. Majano P.L. Lorente R. et al.

Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins [J].

J Viral Hepat. 12: 27-37Antonelli A. Ferrari S.M. Ruffilli I. et al.

Cytokines and HCV-related autoimmune disorders [J].

Immunol Res. 60: 311-319Antonelli A. Ferri C. Ferrari S.M. et al.

Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia [J].

Autoimmun Rev. 8: 18-23Cai Y. Yu X. Hu S. et al.

A brief review on the mechanisms of miRNA regulation [J].

Genomics Proteomics Bioinformatics. 7: 147-154

Circulating microRNAs as novel biomarkers for diabetes mellitus [J].

Nat Rev Endocrinol. 9: 513-521Liu X. Wang T. Wakita T. et al.

Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells [J].

Virology. 398: 57-67Esau C. Davis S. Murray S.F. et al.

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting [J].

Cell Metab. 3: 87-98Anadol E. Schierwagen R. Elfimova N. et al.

Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients [J].

Hepatology. 61: 46-55Jansen C. Reiberger T. Huang J. et al.

Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection [J].

PLoS One. 10e0116768Jopling C.L. Yi M. Lancaster A.M. et al.

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA [J].

Science. 309: 1577-1581Noble J.A. Valdes A.M. Varney M.D. et al.

HLA class I and genetic susceptibility to type 1 diabetes: results from the type 1 diabetes genetics consortium [J].

Diabetes. 59: 2972-2979

Genetics of the HLA region in the prediction of type 1 diabetes [J].

Curr Diab Rep. 11: 533-542Fitzmaurice K. Hurst J. Dring M. et al.

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection [J].

Gut. 64: 813-819Mckiernan S.M. Hagan R. Curry M. et al.

Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source [J].

Hepatology. 40: 108-114Thio C.L. Thomas D.L. Goedert J.J. et al.

Racial differences in HLA class II associations with hepatitis C virus outcomes [J].

J Infect Dis. 184: 16-21Duggal P. Thio C.L. Wojcik G.L. et al.

Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts [J].

Ann Intern Med. 158: 235-245Urabe Y. Ochi H. Kato N. et al.

A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region [J].

J Hepatol. 58: 875-882Cheng Z. Zhou B. Shi X. et al.

Extrahepatic manifestations of chronic hepatitis C virus infection: 297 cases from a tertiary medical center in Beijing, China [J].

Chin Med J (Engl). 127: 1206-1210Turner B.J. Wang C.P.